90 related articles for article (PubMed ID: 16025439)
61. Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants.
Siemionow M; Klimczak A; Unal S; Agaoglu G; Carnevale K
Am J Transplant; 2008 Jun; 8(6):1163-76. PubMed ID: 18444914
[TBL] [Abstract][Full Text] [Related]
62. Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression.
Lott DG; Russell JO; Khariwala SS; Dan O; Strome M
Ann Otol Rhinol Laryngol; 2011 Feb; 120(2):131-6. PubMed ID: 21391426
[TBL] [Abstract][Full Text] [Related]
63. Fas antigen expression of hepatocytes and its modification by immunosuppressants.
Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita M; Takagi H
Dig Dis Sci; 1997 Dec; 42(12):2471-5. PubMed ID: 9440622
[TBL] [Abstract][Full Text] [Related]
64. New surgical approach in facial transplantation extends survival of allograft recipients.
Unal S; Agaoglu G; Zins J; Siemionow M
Ann Plast Surg; 2005 Sep; 55(3):297-303. PubMed ID: 16106171
[TBL] [Abstract][Full Text] [Related]
65. Abstract 104: MHC class I sharing influences the fate of the epidermal component of vascularized composite allografts in mixed chimerism based tolerance protocols in miniature Swine.
Shanmugarajah K; Mallard C; Leonard DA; Albritton A; Powell H; Harrington E; Randolph MA; Sachs DH; Kurtz JM; Cetrulo CL
Plast Reconstr Surg; 2014 Mar; 133(3 Suppl):119. PubMed ID: 25942215
[No Abstract] [Full Text] [Related]
66. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
[TBL] [Abstract][Full Text] [Related]
67. Adenovirus-Mediated CCR7 and BTLA Overexpression Enhances Immune Tolerance and Migration in Immature Dendritic Cells.
Xin H; Zhu J; Miao H; Gong Z; Jiang X; Feng X; Tong Y
Biomed Res Int; 2017; 2017():3519745. PubMed ID: 28393074
[TBL] [Abstract][Full Text] [Related]
68. Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience.
Siemionow M; Klimczak A
Clin Dev Immunol; 2013; 2013():831410. PubMed ID: 23573114
[TBL] [Abstract][Full Text] [Related]
69. Living bone allotransplants survive by surgical angiogenesis alone: development of a novel method of composite tissue allotransplantation.
Larsen M; Pelzer M; Friedrich PF; Wood CM; Bishop AT
J Bone Joint Surg Am; 2011 Feb; 93(3):261-73. PubMed ID: 21266640
[TBL] [Abstract][Full Text] [Related]
70. Facial transplantation.
Siemionow M; Kulahci Y
Semin Plast Surg; 2007 Nov; 21(4):259-68. PubMed ID: 20567679
[TBL] [Abstract][Full Text] [Related]
71. Experimental models of composite tissue allograft transplants.
Siemionow M; Kulahci Y
Semin Plast Surg; 2007 Nov; 21(4):205-12. PubMed ID: 20567673
[TBL] [Abstract][Full Text] [Related]
72. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
73. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
[TBL] [Abstract][Full Text] [Related]
74. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
75. Immunodepletive anti-alpha/beta-TCR antibody in transplantation of composite tissue allografts: Cleveland Clinic research experience.
Siemionow M; Klimczak A
Immunotherapy; 2009 Jul; 1(4):585-98. PubMed ID: 20635989
[TBL] [Abstract][Full Text] [Related]
76. Immunologic responses in vascularized and nonvascularized skin allografts.
Siemionow M; Nasir S
J Reconstr Microsurg; 2008 Oct; 24(7):497-505. PubMed ID: 18798138
[TBL] [Abstract][Full Text] [Related]
77. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
